TrialEuropean journal of clinical pharmacology2019

Interaction potential of the dual orexin receptor antagonist ACT-541468 with CYP3A4 and food: results from two interaction studies.

Marie-Laure Boof et al.PubMed ↗Publisher ↗

No numbers read from the abstract.